Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Plos One|December 17, 2009
Residual antimalarials in malaria patients from Tanzania--implications on drug efficacy assessment and spread of parasite resistanceEva Maria Hodel, Abdunoor Mulokozi Kabanywanyi, Aggrey Malila, et al.
BMC Microbiology|September 5, 2012
Drug resistance-conferring mutations in Mycobacterium tuberculosis from Madang, Papua New GuineaMarie Ballif, Paul Harino, Serej Ley, et al.
The Journal of Infectious Diseases|June 28, 2008
Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1Jutta Marfurt, Frédérique de Monbrison, Sara Brega, et al.
Tropical Medicine & International Health : TM & IH|February 16, 2007
Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatmentKefas Mugittu, Gerardo Priotto, Jean-Paul Guthmann, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 2, 2014
A Plasmodium falciparum PHIST protein binds the virulence factor PfEMP1 and comigrates to knobs on the host cell surfaceAlexander Oberli, Leanne M Slater, Erin Cutts, et al.
The Journal of Infectious Diseases|January 6, 2010
Quantifying the evolution and impact of antimalarial drug resistance: drug use, spread of resistance, and drug failure over a 12-year period in Papua New GuineaChristian Nsanzabana, Ian M Hastings, Jutta Marfurt, et al.
Cellular Microbiology|October 26, 2019
The PHIST protein GEXP02 targets the host cytoskeleton during sexual development of Plasmodium falciparumJan D Warncke, Armin Passecker, Enja Kipfer, et al.
The American Journal of Tropical Medicine and Hygiene|November 4, 2011
Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysisMichael Makanga, Quique Bassat, Catherine O Falade, et al.
Pageof 10